Global Methicillin-Susceptible Staphylococcus Aureus Market Size, Status and Forecast 2021-2027
Table of Content
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
- 1.2.2 Cephalosporins
- 1.2.3 Vancomycin
- 1.2.4 Linezolid
- 1.2.5 Others
- 1.3 Market by Application
- 1.3.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Application: 2016 VS 2021 VS 2027
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Perspective (2016-2027)
- 2.2 Methicillin-Susceptible Staphylococcus Aureus Growth Trends by Regions
- 2.2.1 Methicillin-Susceptible Staphylococcus Aureus Market Size by Regions: 2016 VS 2021 VS 2027
- 2.2.2 Methicillin-Susceptible Staphylococcus Aureus Historic Market Share by Regions (2016-2021)
- 2.2.3 Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Regions (2022-2027)
- 2.3 Methicillin-Susceptible Staphylococcus Aureus Industry Dynamic
- 2.3.1 Methicillin-Susceptible Staphylococcus Aureus Market Trends
- 2.3.2 Methicillin-Susceptible Staphylococcus Aureus Market Drivers
- 2.3.3 Methicillin-Susceptible Staphylococcus Aureus Market Challenges
- 2.3.4 Methicillin-Susceptible Staphylococcus Aureus Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Revenue
- 3.1.1 Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Revenue (2016-2021)
- 3.1.2 Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Players (2016-2021)
- 3.2 Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Methicillin-Susceptible Staphylococcus Aureus Revenue
- 3.4 Global Methicillin-Susceptible Staphylococcus Aureus Market Concentration Ratio
- 3.4.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Methicillin-Susceptible Staphylococcus Aureus Revenue in 2020
- 3.5 Methicillin-Susceptible Staphylococcus Aureus Key Players Head office and Area Served
- 3.6 Key Players Methicillin-Susceptible Staphylococcus Aureus Product Solution and Service
- 3.7 Date of Enter into Methicillin-Susceptible Staphylococcus Aureus Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Methicillin-Susceptible Staphylococcus Aureus Breakdown Data by Type
- 4.1 Global Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by Type (2016-2021)
- 4.2 Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Type (2022-2027)
5 Methicillin-Susceptible Staphylococcus Aureus Breakdown Data by Application
- 5.1 Global Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by Application (2016-2021)
- 5.2 Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Application (2022-2027)
6 North America
- 6.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
- 6.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
- 6.2.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
- 6.2.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
- 6.2.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
- 6.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
- 6.3.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
- 6.3.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
- 6.3.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
- 6.4 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
- 6.4.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
- 6.4.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
- 6.4.3 United States
- 6.4.4 Canada
7 Europe
- 7.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
- 7.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
- 7.2.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
- 7.2.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
- 7.2.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
- 7.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
- 7.3.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
- 7.3.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
- 7.3.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
- 7.4 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
- 7.4.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
- 7.4.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic
8 Asia-Pacific
- 8.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
- 8.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
- 8.2.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
- 8.2.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
- 8.2.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
- 8.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
- 8.3.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
- 8.3.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
- 8.3.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
- 8.4 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region
- 8.4.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2016-2021)
- 8.4.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2022-2027)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
- 9.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
- 9.2.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
- 9.2.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
- 9.2.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
- 9.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
- 9.3.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
- 9.3.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
- 9.3.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
- 9.4 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
- 9.4.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
- 9.4.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
- 10.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
- 10.2.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
- 10.2.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
- 10.2.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
- 10.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
- 10.3.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
- 10.3.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
- 10.3.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
- 10.4 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
- 10.4.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
- 10.4.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Dainippon Sumitomo Pharma Co., Ltd
- 11.1.1 Dainippon Sumitomo Pharma Co., Ltd Company Details
- 11.1.2 Dainippon Sumitomo Pharma Co., Ltd Business Overview
- 11.1.3 Dainippon Sumitomo Pharma Co., Ltd Methicillin-Susceptible Staphylococcus Aureus Introduction
- 11.1.4 Dainippon Sumitomo Pharma Co., Ltd Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
- 11.1.5 Dainippon Sumitomo Pharma Co., Ltd Recent Development
- 11.2 Immtech Pharmaceuticals, Inc.
- 11.2.1 Immtech Pharmaceuticals, Inc. Company Details
- 11.2.2 Immtech Pharmaceuticals, Inc. Business Overview
- 11.2.3 Immtech Pharmaceuticals, Inc. Methicillin-Susceptible Staphylococcus Aureus Introduction
- 11.2.4 Immtech Pharmaceuticals, Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
- 11.2.5 Immtech Pharmaceuticals, Inc. Recent Development
- 11.3 Lytix Biopharma AS
- 11.3.1 Lytix Biopharma AS Company Details
- 11.3.2 Lytix Biopharma AS Business Overview
- 11.3.3 Lytix Biopharma AS Methicillin-Susceptible Staphylococcus Aureus Introduction
- 11.3.4 Lytix Biopharma AS Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
- 11.3.5 Lytix Biopharma AS Recent Development
- 11.4 PharmaIN Corporation
- 11.4.1 PharmaIN Corporation Company Details
- 11.4.2 PharmaIN Corporation Business Overview
- 11.4.3 PharmaIN Corporation Methicillin-Susceptible Staphylococcus Aureus Introduction
- 11.4.4 PharmaIN Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
- 11.4.5 PharmaIN Corporation Recent Development
- 11.5 Cubist Pharmaceuticals
- 11.5.1 Cubist Pharmaceuticals Company Details
- 11.5.2 Cubist Pharmaceuticals Business Overview
- 11.5.3 Cubist Pharmaceuticals Methicillin-Susceptible Staphylococcus Aureus Introduction
- 11.5.4 Cubist Pharmaceuticals Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
- 11.5.5 Cubist Pharmaceuticals Recent Development
- 11.6 Kenta Biotech AG
- 11.6.1 Kenta Biotech AG Company Details
- 11.6.2 Kenta Biotech AG Business Overview
- 11.6.3 Kenta Biotech AG Methicillin-Susceptible Staphylococcus Aureus Introduction
- 11.6.4 Kenta Biotech AG Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
- 11.6.5 Kenta Biotech AG Recent Development
- 11.7 Arsanis Biosciences GmbH
- 11.7.1 Arsanis Biosciences GmbH Company Details
- 11.7.2 Arsanis Biosciences GmbH Business Overview
- 11.7.3 Arsanis Biosciences GmbH Methicillin-Susceptible Staphylococcus Aureus Introduction
- 11.7.4 Arsanis Biosciences GmbH Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
- 11.7.5 Arsanis Biosciences GmbH Recent Development
- 11.8 Volcano Corporation
- 11.8.1 Volcano Corporation Company Details
- 11.8.2 Volcano Corporation Business Overview
- 11.8.3 Volcano Corporation Methicillin-Susceptible Staphylococcus Aureus Introduction
- 11.8.4 Volcano Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
- 11.8.5 Volcano Corporation Recent Development
- 11.9 Abbott Laboratories
- 11.9.1 Abbott Laboratories Company Details
- 11.9.2 Abbott Laboratories Business Overview
- 11.9.3 Abbott Laboratories Methicillin-Susceptible Staphylococcus Aureus Introduction
- 11.9.4 Abbott Laboratories Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
- 11.9.5 Abbott Laboratories Recent Development
- 11.10 AngioScore Inc.
- 11.10.1 AngioScore Inc. Company Details
- 11.10.2 AngioScore Inc. Business Overview
- 11.10.3 AngioScore Inc. Methicillin-Susceptible Staphylococcus Aureus Introduction
- 11.10.4 AngioScore Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
- 11.10.5 AngioScore Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Description
Global Methicillin-Susceptible Staphylococcus Aureus Scope and Market Size
Methicillin-Susceptible Staphylococcus Aureus market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Methicillin-Susceptible Staphylococcus Aureus market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cephalosporins
Vancomycin
Linezolid
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Dainippon Sumitomo Pharma Co., Ltd
Immtech Pharmaceuticals, Inc.
Lytix Biopharma AS
PharmaIN Corporation
Cubist Pharmaceuticals
Kenta Biotech AG
Arsanis Biosciences GmbH
Volcano Corporation
Abbott Laboratories
AngioScore Inc.